SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-041582
Filing Date
2023-05-19
Accepted
2023-05-19 16:53:30
Documents
133
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_bimiintern.htm   iXBRL 10-Q 1106935
2 CERTIFICATION f10q0323ex31-1_bimiintern.htm EX-31.1 9863
3 CERTIFICATION f10q0323ex31-2_bimiintern.htm EX-31.2 9884
4 CERTIFICATION f10q0323ex32-1_bimiintern.htm EX-32.1 3611
5 CERTIFICATION f10q0323ex32-2_bimiintern.htm EX-32.2 3824
  Complete submission text file 0001213900-23-041582.txt   9339586

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bimi-20230331.xsd EX-101.SCH 168914
7 XBRL CALCULATION FILE bimi-20230331_cal.xml EX-101.CAL 61904
8 XBRL DEFINITION FILE bimi-20230331_def.xml EX-101.DEF 519337
9 XBRL LABEL FILE bimi-20230331_lab.xml EX-101.LAB 960438
10 XBRL PRESENTATION FILE bimi-20230331_pre.xml EX-101.PRE 556336
127 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_bimiintern_htm.xml XML 1139075
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34890 | Film No.: 23941146
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries